» Articles » PMID: 31533862

Preoperative Serum C-reactive Protein Levels and Postoperative Survival in Patients with Esophageal Squamous Cell Carcinoma: a Propensity Score Matching Analysis

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: This study tested the relationship between preoperative serum C-reactive protein (CRP) levels and cancer-specific prognosis in patients with esophageal squamous cell carcinoma who have undergone curative resection.

Methods: We conducted a retrospective study on 961 patients with esophageal squamous cell cancer who underwent curative esophagectomy from 2006 to 2012 at the Sun Yat-sen University Cancer Center. Preoperative serum CRP levels were determined, and a cutoff value of 5.0 mg/mL was established. Propensity score matching (PSM) was performed to reduce the selection bias between patients with low CRP (≤ 5.0 mg/mL) and those with high CRP (> 5.0 mg/mL) levels based on age, tumor-lymph node-metastasis (TNM) stage, and tumor grade. The prognostic value of preoperative CRP levels was determined using life table, Kaplan-Meier, and Cox proportional hazards analyzes.

Results: In the unmatched cohort, the 3-year and 5-year survival rates were 57 and 53%, respectively, in patients with high preoperative CRP levels (> 5.0 mg/mL) and 68 and 56%, respectively, in those with low preoperative CRP levels (≤ 5.0 mg/mL). The difference in the survival rates of the 2 groups was significant (p = 0.004). Univariate survival analysis revealed that the preoperative CRP levels, TNM stage, tumor grade, drinking history, and anastomosis method were prognostic factors for overall survival (OS). Before conducting PSM, the low-CRP group had a lower age (p = 0.001), lower histological grade (p = 0.086), and lower TNM stage (p = 0.254). After PSM, 176 patients with low CRP levels and 176 of those with high CRP levels were enrolled in the analysis. In the matched cohort, the 3-year and 5-year survival rates were 56 and 50%, respectively, in patients with high preoperative CRP levels (> 5.0 mg/mL) and 68 and 56%, respectively, in those with low preoperative CRP levels (≤ 5.0 mg/mL). The difference in the survival rates between the low- and high-CRP groups was significant (p = 0.044). Multivariate analysis of the matched patients revealed that the TNM stage and preoperative CRP level were independent prognostic factors for OS.

Conclusions: A high preoperative CRP level (> 5.0 mg/mL) predicts worse survival prognosis in patients who have undergone curative resection for esophageal squamous cell cancer.

Citing Articles

Role of C-reactive protein in disease progression, diagnosis and management.

Ali S, Zehra A, Khalid M, Hassan M, Shah S Discoveries (Craiova). 2024; 11(4):e179.

PMID: 39554800 PMC: 11569793. DOI: 10.15190/d.2023.18.


The Significance of C-Reactive Protein Value and Tumor Grading for Malignant Tumors: A Systematic Review.

Siancu P, Oprinca G, Vulcu A, Patran M, Croitoru A, Tanasescu D Diagnostics (Basel). 2024; 14(18).

PMID: 39335753 PMC: 11430861. DOI: 10.3390/diagnostics14182073.


The molecular characteristics could supplement the staging system of pT2/T3N0M0 esophageal squamous cell carcinoma: a translational study based on a cohort with over 20 years of follow-up.

Jiang W, Tian J, Guo Y, Qiu L, Luo X, Huang Y Cancer Cell Int. 2024; 24(1):119.

PMID: 38553712 PMC: 10981364. DOI: 10.1186/s12935-024-03286-5.


Clinical Significance of the Preoperative Inflammatory Burden Index in Esophageal Cancer.

Yin C, Okugawa Y, Kitajima T, Shimura T, Ma R, Kawamura M Oncology. 2023; 102(7):556-564.

PMID: 38142688 PMC: 11216362. DOI: 10.1159/000535727.


C-Reactive Protein: Pathophysiology, Diagnosis, False Test Results and a Novel Diagnostic Algorithm for Clinicians.

Mouliou D Diseases. 2023; 11(4).

PMID: 37873776 PMC: 10594506. DOI: 10.3390/diseases11040132.


References
1.
Dresner S, Griffin S . Pattern of recurrence following radical oesophagectomy with two-field lymphadenectomy. Br J Surg. 2000; 87(10):1426-33. DOI: 10.1046/j.1365-2168.2000.01541.x. View

2.
Nozoe T, Matsumata T, Sugimachi K . Serum level of C-reactive protein may be a marker for proliferation of esophageal carcinoma. Hepatogastroenterology. 2001; 47(36):1622-3. View

3.
Shimada H, Takeda A, Nabeya Y, Okazumi S, Matsubara H, Funami Y . Clinical significance of serum vascular endothelial growth factor in esophageal squamous cell carcinoma. Cancer. 2001; 92(3):663-9. DOI: 10.1002/1097-0142(20010801)92:3<663::aid-cncr1368>3.0.co;2-l. View

4.
Nozoe T, Saeki H, Sugimachi K . Significance of preoperative elevation of serum C-reactive protein as an indicator of prognosis in esophageal carcinoma. Am J Surg. 2001; 182(2):197-201. DOI: 10.1016/s0002-9610(01)00684-5. View

5.
Shimada H, Takeda A, Shiratori T, Nabeya Y, Okazumi S, Matsubara H . Prognostic significance of serum thymidine phosphorylase concentration in esophageal squamous cell carcinoma. Cancer. 2002; 94(7):1947-54. DOI: 10.1002/cncr.10418. View